Onco Wiki / drapeau rouge

Carcinome à cellules squameuses du pénis, à haute intensité de MSI/dMMR — un sous-système biomarqueur peu fréquent mais décrit...

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDRF-PENILE-SCC-MSI-H-ACTIONABILITY
TypeSignal d’alerte
Étatreviewed 2026-07-11 | pending_clinical_signoff
MaladiesDIS-PENILE-SCC
SourcesSRC-EAU-PENILE-2024

Origine du drapeau rouge

DéfinitionMSI-high / dMMR penile squamous cell carcinoma — an uncommon but described biomarker subset. Opens pembrolizumab (tissue-agnostic MSI-H/dMMR FDA approval, KEYNOTE-158/164 basket) as an alternative to cisplatin-based chemotherapy in metastatic/unresectable disease.
Direction cliniqueintensifier
Catégoriehigh-risk-biology
Algorithme de décalageALGO-PENILE-SCC-1L

Logique de déclenchement

{
  "any_of": [
    {
      "finding": "msi_status",
      "value": "MSI-H"
    },
    {
      "finding": "dmmr_status",
      "value": "deficient"
    }
  ],
  "type": "biomarker"
}

Notes

STUB. Drafted for the DIS-PENILE-SCC Phase 1 authoring pass. MSI-H is rare in penile SCC and testing is not routine — this RF fires only when MSI/dMMR testing has actually been performed and returns positive. Mirrors RF-CRC-MSI-H-ACTIONABILITY's trigger/finding-key convention (finding: msi_status / dmmr_status) for consistency across the KB. Requires clinical co-lead signoff before publication (CHARTER §6.1; dev-mode-exempted for draft merge).

Utilisé par

Algorithmes

Indication